Sofosbuvir Completed Phase 4 Trials for Hepatitis C Viral Infection / Hepatitis C Virus (HCV) Infection Treatment

CompletedTreatment4 IdentifierTitleDrugs
NCT02992457Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection
NCT02064049Surveillance and Treatment of Prisoners With Hepatitis C
NCT02347345Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs
NCT02631772LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
NCT03200184Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients
NCT02156570DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)
NCT02214420SMV + SOF With/Without RBV for IFN-II Patients With CHC
NCT02768961Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C)
NCT03069001Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV